<?xml version="1.0" encoding="UTF-8"?>
<ref id="B19">
 <label>19</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Pines</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>Targeting TGF
   <italic>Î²</italic> signaling to inhibit fibroblast activation as a therapy for fibrosis and cancer: effect of halofuginone
  </article-title>
  <source>
   <italic toggle="yes">Expert Opinion on Drug Discovery</italic>
  </source>
  <year>2008</year>
  <volume>3</volume>
  <issue>1</issue>
  <fpage>11</fpage>
  <lpage>20</lpage>
  <pub-id pub-id-type="doi">10.1517/17460441.3.1.11</pub-id>
  <pub-id pub-id-type="other">2-s2.0-38849209865</pub-id>
  <pub-id pub-id-type="pmid">23480137</pub-id>
 </element-citation>
</ref>
